Zhejiang Conba Pharmaceutical Announces Special Shareholders' Meeting to Review 2026 Annual Routine Related-Party Transaction Estimates

China Interview Network DataZhejiangConbaZhejiang Conba Pharmaceutical Co., Ltd. (Stock Code: 600572) announced on January 24 that it will convene its first extraordinary shareholders' meeting of 2026 on February 9, 2026, via a combination of on-site and online voting. The core agenda of this meeting is to deliberate on the "Proposal Regarding the Estimated Daily Related Party Transactions for the Year 2026." This proposal includes three specific estimates for 2026: transactions between the company and related parties in Zhejiang Province.Inte GroupZhejiang Conba Pharmaceutical Co., Ltd. expects to engage in daily related-party transactions amounting to no more than RMB 1,012 million; with related party Conba Group Co., Ltd., the expected amount of daily related-party transactions is RMB 153.31 million; with related party Jiangxi Zhenshiming Pharmaceutical Co., Ltd., the expected amount of daily related-party transactions is RMB 6 million. The above proposal has been approved by the company's board of directors, and related shareholders must abstain from voting on the corresponding sub-proposals. Among them, Zhejiang Pharmaceutical Health Industry Group Co., Ltd. must abstain from voting on proposals related to Intai Group, Conba Group and Hu Jiqiang must abstain from voting on proposals related to Conba Group, and Wu Lüwen must abstain from voting on proposals related to ZSM Company. The record date for this shareholders' meeting is February 2, 2026, and shareholders can participate in the voting either in person or through the Shanghai Stock Exchange online voting system. The meeting will be held at the Conba Center in Binjiang District, Hangzhou City.